Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2005
05/31/2005US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
05/31/2005US6900025 Detection of antibodies to squalene in serum
05/31/2005US6900024 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells
05/31/2005US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES
05/31/2005US6899880 Polypeptide vaccine; induce immunology response
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition
05/26/2005WO2005047897A1 Method of diagnosing alzheimer’s disease
05/26/2005WO2005047860A2 Antibodies to alpha-synuclein
05/26/2005WO2005047542A1 Treatments for inhibiting development and progression of nevi and melanoma having braf mutations
05/26/2005WO2005047512A2 Plasmid system for multigene expression
05/26/2005WO2005047459A2 Sars nucleic acids, proteins, antibodies, and uses thereof
05/26/2005WO2005047458A2 Modified recombinant vaccina viruses and other microorganisms, uses thereof
05/26/2005WO2005047456A2 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
05/26/2005WO2005047338A1 Cancer cell targeting gene delivery method
05/26/2005WO2005047337A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
05/26/2005WO2005047336A1 Protein complex using immunoglobulin fragment andmethod for the preparation thereof
05/26/2005WO2005047335A1 Method for themass production of immunoglobulin constant region
05/26/2005WO2005047334A1 Igg fc fragment for a drug carrier and method for the preparation thereof
05/26/2005WO2005047333A1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof
05/26/2005WO2005047332A1 Adenocarcinoma specific antibody sam-6, and uses thereof
05/26/2005WO2005047331A2 Antibodies that bind interleukin-4 receptor
05/26/2005WO2005047330A1 Endotoxin shock medicine for tlr4-md-2 composite as target
05/26/2005WO2005047329A1 An antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same
05/26/2005WO2005047328A2 Antibodies against secretoryleukocyte protease inhibitor
05/26/2005WO2005047327A2 NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
05/26/2005WO2005047326A2 Interleukin-10 antibodies
05/26/2005WO2005047325A2 Monkey immunoglobulin sequences
05/26/2005WO2005047320A2 Equine p-selection glycoprotein ligand-1 and uses thereof
05/26/2005WO2005047309A2 Prophylactic and therapeutic monoclonal antibodies
05/26/2005WO2005047307A2 Il-18 binding proteins
05/26/2005WO2005046723A1 Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin
05/26/2005WO2005046721A2 Compositions for reducing bacterial carriage and cns invasion and methods of using same
05/26/2005WO2005046720A2 Diagnosis, prognosis and treatment of pulmonary diseases using foxa2
05/26/2005WO2005046713A1 Proteins involved in quorum sensing
05/26/2005WO2005046711A2 Stimulation or inhibition of gamma delta t-cells to promote or inhibit bone healing
05/26/2005WO2005046657A2 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease
05/26/2005WO2005046602A2 Vegf receptor antagonists
05/26/2005WO2005046597A2 Antibodies to cd44 glycoforms and uses thereof
05/26/2005WO2005046583A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes
05/26/2005WO2005046573A2 Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
05/26/2005WO2005046564A2 Diagnosis and treatment of liver fibrosis
05/26/2005WO2005031309A3 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways
05/26/2005WO2005025617A3 Methods and compositions for treating herpes infections
05/26/2005WO2005021711A3 Approach for obtaining monoclonal antibodies to cell surface proteins
05/26/2005WO2005016951A3 Anti-ghrelin fab antibodies
05/26/2005WO2005010048A3 Rg1 antibodies and uses thereof
05/26/2005WO2005009363A3 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies
05/26/2005WO2005009217A3 Diagnosis of pre-cancerous conditions using pcdgf agents
05/26/2005WO2005003158A3 Compositions and methods for increasing bone mineralization
05/26/2005WO2005000207A3 Pcdgf receptor antibodies and methods of use thereof
05/26/2005WO2004103294A3 Methods and compositions for the prevention and treatment of sepsis
05/26/2005WO2004099784A3 Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
05/26/2005WO2004056312A3 Immunoglobulin variants and uses thereof
05/26/2005WO2003085081A3 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
05/26/2005WO2002094854A8 P.aeruginosa mucoid exopolysaccharide specific binding peptides
05/26/2005US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
05/26/2005US20050113564 Chimeric receptors with 4-1BB stimulatory signaling domain
05/26/2005US20050113562 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof
05/26/2005US20050113329 Contacing cell/body fluid with antibody which binds human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide; for inhibiting tumor growth; gene expression inhibition; immunization
05/26/2005US20050113304 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
05/26/2005US20050113298 Receptor binding peptides derived from the SARS S protein
05/26/2005US20050113284 Drug for regenerating tissue and vessel and method therefor
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112705 Detecting cancer perticularly of prostate gland
05/26/2005US20050112704 Method of isolating CD8+ cells, and related hybridoma cells, antibodies and polypeptides
05/26/2005US20050112698 Antibody library; determination stem cell factor using antibody
05/26/2005US20050112696 Determination moderator of beta-secretase on proteins
05/26/2005US20050112694 Antibody mixture containing heavy and light chains
05/26/2005US20050112690 Binding molecules for the extra-domain B of fibronectin for detection of arteriosclerotic plaque
05/26/2005US20050112681 Isolated human transporter proteins, nucleic acid molecules encoding human, transporter proteins, and uses thereof
05/26/2005US20050112675 Polypeptides gene expressed in fat tissue ; measurement concentration; using antibodies
05/26/2005US20050112642 Fibroblast growth factor receptors and methods for their use
05/26/2005US20050112641 Protein mixture which confers antibiotic resistance
05/26/2005US20050112596 APRIL-A novel protein with growth effect
05/26/2005US20050112582 Antibodies for the alpha platelet-derived growth factor receptor
05/26/2005US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility
05/26/2005US20050112574 Isolated nucleic acid; angiogenesis inhibitor
05/26/2005US20050112568 Dgks as modifiers of the p53 pathwha and methods of use
05/26/2005US20050112565 Proteases
05/26/2005US20050112559 Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)
05/26/2005US20050112150 Promoting exfoliation; mixture of polypeptide and protease; skin disorders; antitumor agents
05/26/2005US20050112133 Chimera molecule containing protein and merozonite surface protein; induce immunologyresponse against antigens
05/26/2005US20050112130 Enhanced B cell cytotoxicity of CDIM binding antibody
05/26/2005US20050112129 Compositions and methods for the diagnosis and treatment of tumors of glial origin
05/26/2005US20050112127 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
05/26/2005US20050112126 Anti-VEGF antibodies
05/26/2005US20050112125 Methods of modulating lipid metabolism and storage
05/26/2005US20050112124 Methods of treating sickle cell disease
05/26/2005US20050112123 Methods of treating proteinuria
05/26/2005US20050112122 Generation of hematopoietic chimerism and induction of central tolerance
05/26/2005US20050112120 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
05/26/2005US20050112119 Antibodies which bind human CXCR3
05/26/2005US20050112118 Compositions and methods for treating inflammatory disorders
05/26/2005US20050112117 Molecules and methods for inhibiting shedding of KIM-1
05/26/2005US20050112116 Bioassay of a NMO-specific autoantibody: contacting a biological sample with a NMO antigenic polypeptide, aquaporin-4; and detecting the binding of the NMO antigenic polypeptide to the NMO-specific autoantibody; vision impairment, weakness, numbness, spasms, abnormal or painful sensations
05/26/2005US20050112090 Enhanced apoptosisinduced by tumor necrosis factor; administering to cell a polypeptide that gene expresses antagonist to tumor necrosis factor; anticancer agents; autoimmune diseases
05/26/2005US20050112062 Anti-idiotypic vascular endothelial growth factor antibodies and their use as medicaments
05/26/2005CA2812856A1 Interleukin-10 antibodies
05/26/2005CA2805859A1 Il-18 binding proteins
1 ... 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 ... 1494